-
Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022
-
View Affiliations Hide AffiliationsCèlia Ventura-Gabarrócelia.ventura-gabarro ecdc.europa.eu
-
View Collaborators
ESAC-Net study group participants: Reinhild Strauss, Lucy Catteau, Ivan Stoikov, Marina Payerl-Pal, Isavella Kyriakidou, Michal Prokeš, Majda Attauabi, Janne Sepp, Emmi Sarvikivi, Karima Hider-Mlynarz, Birgitta Schweickert, Kassiani Mellou, Maria Matuz, Anna Margrét Halldórsdóttir, Emre Umut Gurpinar, Filomena Fortinguerra, Ieva Rutkovska, Rolanda Valinteliene, Stéphanie Saleh, Peter Zarb, Jan Baltink, Hege Salvesen Blix, Anna Olczak-Pieńkowska, Ana Silva, Gabriel Adrian Popescu, Tomáš Tesař, Maja Subelj, Antonio López-Navas, Ragda ObeidView Citation Hide Citation
Citation style for this article: . Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022. Euro Surveill. 2023;28(46):pii=2300604. https://doi.org/10.2807/1560-7917.ES.2023.28.46.2300604 Received: 03 Nov 2023; Accepted: 15 Nov 2023
- Previous Article
- Table of Contents
- Next Article
Abstract
We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to pre-COVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Full text loading...